• The most important factor that predicts the risk of MTCT is the level of HIV virological suppression at delivery and is dependent on adherence to an antiretroviral drug regime
• To reduce MTCT all pregnant women with HIV should have commenced ARV therapy by 24 weeks 
• It takes time for ARV regimes to work. For the majority of cases presenting early, complete suppression should be achievable by 12-14 weeks after initiation of ARVs
• If VL is undetectable and there are no other risks the woman’s management during labour and delivery should follow the same guidelines as for any pregnant woman
  
• Women may require ongoing support and information in relation to the importance of adhering to treatment and reducing MTCT

Next >>